{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T18:32:51Z","timestamp":1793817171133,"version":"4.6.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"13","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2018,10,29]]},"abstract":"<jats:sec>\n<jats:title>Background: <\/jats:title>\n<jats:p>Microdose lithium is protective against Alzheimer\u2019s disease (AD), although the\nprecise mechanisms through which its protective effects are conferred remain unclear.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Objective: <\/jats:title>\n<jats:p> To further examine the effects during the earliest stages of A\u03b2 pathology, we evaluated\nwhether NP03, a microdose lithium formulation, modulates A\u03b2-mediated oxidative damage and neuroinflammation\nwhen applied to a rat transgenic model of AD-like amyloidosis overexpressing amyloid precursor\nprotein (APP).\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p> McGill-R-Thy1-APP transgenic rats and wild-type littermates were treated with NP03 or vehicle\nformulation for 8 weeks beginning at 3 months of age - a phase preceding A\u03b2 plaque deposition in\nthe transgenic rats.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p> Oxidative and nitrosative stress markers, protein-bound 4-hydroxynonenal (HNE) and proteinresident\n3-nitrotyrosine (3-NT), inflammatory cytokines production, as well as microglial recruitment\ntowards A\u03b2-burdened neurons were assayed. NP03 significantly decreased cerebral HNE and 3-NT, and\nreduced production of pro-inflammatory cytokines in McGill-R-Thy1-APP transgenic rats. NP03 further\nreduced expression of microglia surface receptor Trem2 and led to a corresponding reduction in microglia\nrecruitment towards A\u03b2-burdened neurons in the CA1 region of the hippocampus.\n<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p> These results suggest that NP03 may function to slow the AD-like pathology in part by\nmodifying oxidative\/nitrosative damage and neuroinflammation, raising the possibility that low doses of\nmicroencapsulated lithium might be of therapeutic-preventive value during very early or preclinical AD.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205015666180904154446","type":"journal-article","created":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T04:45:47Z","timestamp":1536641147000},"page":"1220-1230","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Microdose Lithium NP03 Diminishes Pre-Plaque Oxidative Damage and Neuroinflammation in a Rat Model of Alzheimer\u2019s-like Amyloidosis"],"prefix":"10.2174","volume":"15","author":[{"given":"Edward N.","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurosurgery, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Do Carmo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Florencia","family":"Iulita","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant L.","family":"Austin","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Kentucky, Lexington, KY 40506, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan T.","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice C.","family":"Malcolm","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan K.","family":"Foret","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam R.","family":"Marks","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Allan","family":"Butterfield","sequence":"additional","affiliation":[{"name":"Department of Chemistry, University of Kentucky, Lexington, KY 40506, United States"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Claudio","family":"Cuello","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Therapeutics, McGill University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/165117","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/165117\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/165117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T16:01:53Z","timestamp":1609257713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/165117\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,29]]},"references-count":0,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2018,10,29]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205015666180904154446","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10,29]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-05-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-08-31","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-10-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}